RE:What is the street consensus here?I'd also like thoughts on the fact that Toray, a company Spectral has a business relationship with, supplied content for this review. I would think that if the nature of the relationship with Toray has changed, Spectral would have had to report it. Also as curious to me, it has been only 5 weeks since Spectral updated us on their resubmission process to the FDA. If things were as dire (relative to individual interpretation) as the review describes, wouldn't the FDA have outright shut Spectral down?
FrostytheDoeman wrote: Only shows GMP on company website even though 2 analysts are shown as covering.
What are the buy, sell and hold decisions along with price target?
Will this poor paper influence the analysts?
Serious replies only please and thanks!